Substituted pyridines as selective cyclooxygenase-2 inhibitors
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
Merck & Co., Inc.
C C C C C C C
C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional
Jacques Yves Zhaoyin Daniel Rejean Richard
Gauthier Wang Dube Fortin Friesen